Affordable Access

Publisher Website

P061: Early detection and successful control of vancomycin resistant Enterococcus faecium (VRE) outbreak in an academic hospital in Pretoria, South Africa

Authors
Journal
Antimicrobial Resistance and Infection Control
2047-2994
Publisher
Springer (Biomed Central Ltd.)
Publication Date
Volume
2
Identifiers
DOI: 10.1186/2047-2994-2-s1-p61
Keywords
  • Poster Presentation
Disciplines
  • Biology
  • Medicine

Abstract

P061: Early detection and successful control of vancomycin resistant Enterococcus faecium (VRE) outbreak in an academic hospital in Pretoria, South Africa POSTER PRESENTATION Open Access P061: Early detection and successful control of vancomycin resistant Enterococcus faecium (VRE) outbreak in an academic hospital in Pretoria, South Africa RM Lekalakala1*, E Iewis2, E Silberbauer3 From 2nd International Conference on Prevention and Infection Control (ICPIC 2013) Geneva, Switzerland. 25-28 June 2013 Introduction Active surveillance which was introduced in 2008 fol- lowing the Clostridium difficile outbreak in our hospital enhanced early detection of vancomycin resistant Enter- ococcus faeciumoutbreak in the medical intensive care unit (MICU). Prompt intervention strategies which were implemented by infection control team facilitated the successful control. Background A maximum of 10 VRE isolates per year has been the norm between 2008 and 2011 in our 800 bed hospital. These isolates were from the oncology units. Between the 4th and 30th August 2012, 7 patients in MICU had VRE positive cultures from a variety of samples includ- ing blood cultures. Methods Sample types and patient clinical data were collected; movement of infected patients within the hospital was traced to identify the possible index patient for patients who were not admitted directly into MICU. Hand wash- ing and contact precautions practises were audited and reinforced as per VRE policy. Environmental cleaning audits were done routinely to minimize the bio burden and the unit was closed for new admission other than VRE positive patients. Infection control monthly reports were reviewed from May 2012 for possible oversight as there were no VRE cases in April. Monitoring and recording of new case is on-going with daily update to the team. One Isolate per patient is stored for molecular characterization Results 28 patients were identified over 10 months (May 2012 to February 2013). 42% (12/28) patients from MI

There are no comments yet on this publication. Be the first to share your thoughts.